Search Results - "McDowell, Gladstone"
-
1
Intrathecal Therapy for Chronic Pain: A Review of Morphine and Ziconotide as Firstline Options
Published in Pain medicine (Malden, Mass.) (01-04-2019)“…Abstract Objectives To evaluate the evidence for morphine and ziconotide as firstline intrathecal (IT) analgesia agents for patients with chronic pain. Methods…”
Get full text
Journal Article -
2
Long-Term Follow-Up (>11 Years) on Successful Pregnancies With Ziconotide Monotherapy for Arachnoiditis-Related Chronic Pain
Published in Neuromodulation (Malden, Mass.) (01-08-2023)Get more information
Journal Article -
3
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines
Published in Neuromodulation (Malden, Mass.) (01-02-2017)“…Pain treatment is best performed when a patient-centric, safety-based philosophy is used to determine an algorithmic process to guide care. Since 2007, the…”
Get more information
Journal Article -
4
Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel
Published in Neuromodulation (Malden, Mass.) (01-09-2012)“…The use of intrathecal (IT) infusion of analgesic medications to treat patients with chronic refractory pain has increased since its inception in the 1980s,…”
Get more information
Journal Article -
5
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
Published in Neuromodulation (Malden, Mass.) (01-07-2016)“…Ziconotide is a non-opioid analgesic for intrathecal (IT) administration. The aim of this review is to provide a comprehensive and clinically relevant summary…”
Get more information
Journal Article -
6
The appropriate use of neurostimulation of the spinal cord and peripheral nervous system for the treatment of chronic pain and ischemic diseases: the Neuromodulation Appropriateness Consensus Committee
Published in Neuromodulation (Malden, Mass.) (01-08-2014)“…The Neuromodulation Appropriateness Consensus Committee (NACC) of the International Neuromodulation Society (INS) evaluated evidence regarding the safety and…”
Get more information
Journal Article -
7
Role of primary care physicians in intrathecal pain management: a narrative review of the literature
Published in Postgraduate medicine (19-05-2018)“…Objectives: The majority of patients seeking medical care for chronic pain consult a primary care physician (PCP). Because systemic opioids are commonly…”
Get full text
Journal Article -
8
The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain
Published in Neuromodulation (Malden, Mass.) (01-10-2024)“…The International Neuromodulation Society convened a multispecialty group of physicians and scientists based on expertise with international representation to…”
Get more information
Journal Article -
9
Polyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain
Published in Neuromodulation (Malden, Mass.) (01-09-2012)“…Targeted intrathecal drug infusion to treat moderate to severe chronic pain has become a standard part of treatment algorithms when more conservative options…”
Get more information
Journal Article -
10
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
Published in Pain medicine (Malden, Mass.) (01-11-2020)“…Abstract Background and Objectives The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal…”
Get full text
Journal Article -
11
Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
Published in Pain practice (01-02-2018)“…Background The Patient Registry of Intrathecal Ziconotide Management (PRIZM) evaluated long‐term effectiveness, safety, and tolerability of intrathecal…”
Get full text
Journal Article -
12
Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses)
Published in Neuromodulation (Malden, Mass.) (01-09-2012)“…Continuous intrathecal infusion of drugs to treat chronic pain and spasticity has become a standard part of the algorithm of care. The use of opioids has been…”
Get more information
Journal Article -
13
Administering Ziconotide and Monitoring Patients Treated with Ziconotide: Expert Opinions
Published in Pain management nursing (01-09-2013)“…Some patients with chronic pain who are intolerant of or refractory to treatment with systemic analgesics may benefit from intrathecal therapy. Ziconotide is…”
Get full text
Journal Article -
14
The appropriate use of neurostimulation: avoidance and treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation Appropriateness Consensus Committee
Published in Neuromodulation (Malden, Mass.) (01-08-2014)“…The International Neuromodulation Society (INS) has determined that there is a need for guidance regarding safety and risk reduction for implantable…”
Get more information
Journal Article -
15
A post-market, randomized, controlled, prospective study evaluating intrathecal pain medication versus conventional medical management in the non-cancer, refractory, chronic pain population (PROSPER)
Published in Expert review of medical devices (02-11-2022)“…Intrathecal therapy has been limited by non-randomized prospective studies, particularly for those suffering from non-cancer. Further, no prospective,…”
Get more information
Journal Article -
16
I3 Effectiveness and Safety of Intrathecal Ziconotide Use as the First Agent in Pump
Published in Pain management nursing (01-04-2019)Get full text
Journal Article -
17
Use of Intrathecal Ziconotide for Frequent Severe and Intractable Sickle Cell Disease-Related Pain
Published in Blood (18-11-2011)“…Abstract 1062 Many patients with sickle cell disease (SCD) have recurrent, severe vaso-occlusive pain crises, with profound consequences for their quality of…”
Get full text
Journal Article -
18
I2 Effectiveness and Safety of Intrathecal Ziconotide Use as the First Agent in Pump
Published in Pain management nursing (01-04-2018)Get full text
Journal Article -
19
I1 Sustained Effectiveness of Intrathecal Ziconotide Use in Patients with Severe Chronic Pain
Published in Pain management nursing (01-04-2018)Get full text
Journal Article -
20
I4 Effect of Intrathecal Ziconotide as the First Agent in Pump on Patient-Reported Outcomes
Published in Pain management nursing (01-04-2019)Get full text
Journal Article